New Publication: Brain malformations and seizures by impaired chaperonin function of TRiC

We are excited to share a new publication from our research team! The study “Brain malformations and seizures by impaired chaperonin function of TRiC” uncovers critical genetic mutations linked to severe brain malformations, offering new hope for diagnosis and treatment for rare disease patients worldwide.

The study, led by Prof. Ingo Kurth and his team in Aachen, Germany, revealed that alterations in the TRiC chaperonin complex, specifically the CCT1 through CCT8 genes, may play a pivotal role in a new group of severe brain conditions now known as TRiCopathies.

Through support from Dr. Lochmüller’s Canadian Institutes of Health Research (CIHR) Foundation Grant, our team utilized the RD-Connect Genome Phenome Analysis Platform (GPAP) to analyze genetic data from patients with brain development issues of unknown cause. These efforts, led by postdoc Dr Kiran Polavarapu, led to the identification of several individuals carrying mutations in the TRiC genes, aligning with the expected clinical symptoms of TRiCopathies.

So far, 22 patients across the world have received a confirmed diagnosis through this study, and several additional cases are under ongoing validation.

“This discovery highlights the importance of re-analysis of genetic data, as oftentimes patients with a rare disease may not receive a diagnosis until years later once new genes are discovered and more information emerges. We remain hopeful that in addition to the patients who have received a confirmed diagnosis through this study, more will come, and receive proper care,” said Dr. Lochmüller.

International collaboration is a key factor to the success of improving rare disease care, as patients with similar conditions can be scattered across the globe. By sharing data, researchers can enhance diagnostic accuracy and improve outcomes for affected individuals.

 

This research was recently highlighted by the CHEO Research Institute! See their report on this research.

The publication in Science can be found here.

 

 

New lab publication - Brain malformations and seizures by impaired chaperonin function of TRiC

Read next...

Clinical trial update - Canadian Patient First in the World to Receive Trial Drug in Argenx DOK7-CMS Study

Canadian Patient Receives Trial Drug in Argenx DOK7-CMS Study

Our clinical research team at the NeuroMuscular centre of The Ottawa Hospital is excited to share that a Canadian patient affected by DOK-7 Congenital Myasthenic...
New leadership for the University of Ottawa Centre for Neuromuscular Disease, Drs Mireille Khacho and Hanns Lochmuller.

Drs Hanns Lochmüller and Mireille Khacho New Leaders of University of Ottawa Eric Poulin Centre for Neuromuscular Disease

We are delighted to share exciting news from the uOttawa Brain and Mind Research Institute (uOBMRI)! Drs. Hanns Lochmüller and Mireille Khacho have been appointed...
Dr Lola Lessard and Kelly Ho receive prestigious research poster awards

Lab Members Receive Research Poster Awards at National and International Conferences

Kelly Ho Receives Poster Award at World Muscle Society Congress Congratulations to PhD researcher Kelly Ho, whose poster presentation "Investigating muscle specific kinase antibody treatment...
Clinical trial updates in FSHD

FSHD Clinical Trial Updates

Two clinical trial opportunities in FSHD at The Ottawa NeuroMuscular Centre now recruiting, FSHD community receive negative topline results from phase 3 losmapimod (REACH) trial....
Lessard-funding-DM1_1200x900 (1)

Dr. Lola Lessard Receives Postdoctoral Fellowship to study AMPK signaling in DM1

We are excited to share that  Dr. Lola Lessard has been awarded a one-year postdoctoral research fellowship from AFM-Téléthon to study AMP-activated protein kinase (AMPK)...
Congratulations to the 2024 Lochmuller Lab graduates, Emily Freeman and Catherine Choueiri.

Congratulations to the Lab’s Recent Graduates!

The Lochmüller Lab would like to congratulate two of our members on graduating from PhD and MSc programs at the University of Ottawa this past...